Total Payments
$43,393
2024 Payments
$8,657
Companies
18
Transactions
394
Medicare Patients
3,091
Medicare Billing
$579,894
Payment Breakdown by Category
Travel$17,655 (40.7%)
Food & Beverage$14,032 (32.3%)
Other$11,600 (26.7%)
Education$105.96 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $17,655 | 80 | 40.7% |
| Food and Beverage | $14,032 | 311 | 32.3% |
| Grant | $11,250 | 1 | 25.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $350.00 | 1 | 0.8% |
| Education | $105.96 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $19,564 | 231 | $0 (2024) |
| Medtronic USA, Inc. | $12,630 | 17 | $0 (2020) |
| Boston Scientific Corporation | $5,606 | 30 | $0 (2024) |
| Abbott Laboratories | $2,545 | 26 | $0 (2024) |
| SI-BONE, INC. | $1,561 | 19 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $602.85 | 36 | $0 (2024) |
| Nevro Corp. | $263.26 | 5 | $0 (2023) |
| TerSera Therapeutics LLC | $136.09 | 8 | $0 (2024) |
| Electronic Waveform Lab, Inc. | $130.20 | 7 | $0 (2023) |
| Bioventus LLC | $77.39 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,657 | 87 | Medtronic, Inc. ($4,618) |
| 2023 | $8,563 | 101 | Medtronic, Inc. ($4,578) |
| 2022 | $8,946 | 121 | Medtronic, Inc. ($6,029) |
| 2021 | $4,516 | 66 | Medtronic, Inc. ($4,339) |
| 2020 | $357.28 | 5 | Medtronic USA, Inc. ($338.82) |
| 2019 | $12,353 | 14 | Medtronic USA, Inc. ($12,291) |
All Payment Transactions
394 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: Opioid Analgesic | ||||||
| 12/04/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $127.35 | General |
| 11/02/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $154.43 | General |
| Category: Drug Infusion Systems | ||||||
| 11/02/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $98.67 | General |
| Category: Drug Infusion Systems | ||||||
| 11/02/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $72.04 | General |
| Category: Drug Infusion Systems | ||||||
| 11/02/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $36.59 | General |
| Category: Drug Infusion Systems | ||||||
| 11/02/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: Drug Infusion Systems | ||||||
| 11/02/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: Drug Infusion Systems | ||||||
| 11/02/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Drug Infusion Systems | ||||||
| 11/01/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Travel and Lodging | In-kind items and services | $493.96 | General |
| Category: Drug Infusion Systems | ||||||
| 11/01/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $129.94 | General |
| Category: Drug Infusion Systems | ||||||
| 11/01/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Travel and Lodging | In-kind items and services | $126.12 | General |
| Category: Drug Infusion Systems | ||||||
| 11/01/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Drug Infusion Systems | ||||||
| 11/01/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Drug Infusion Systems | ||||||
| 11/01/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Drug Infusion Systems | ||||||
| 10/31/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Drug Infusion Systems | ||||||
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $8.79 | General |
| Category: Opioid Analgesic | ||||||
| 10/31/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $8.51 | General |
| 10/30/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $170.95 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $51.56 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $44.63 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $422.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/18/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $121.92 | General |
| Category: Drug Infusion Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,008 | 2,211 | $628,174 | $221,747 |
| 2022 | 19 | 1,133 | 2,235 | $567,329 | $219,357 |
| 2021 | 17 | 544 | 1,016 | $294,501 | $100,022 |
| 2020 | 8 | 406 | 448 | $58,940 | $38,768 |
Total Patients
3,091
Total Services
5,910
Medicare Billing
$579,894
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 336 | 1,111 | $168,831 | $68,737 | 40.7% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 12 | 21 | $96,873 | $24,684 | 25.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 34 | 56 | $49,010 | $18,810 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 131 | $28,820 | $12,260 | 42.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 38 | 60 | $40,633 | $11,364 | 28.0% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 67 | 184 | $37,249 | $11,015 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $36,852 | $10,732 | 29.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 32 | 58 | $20,207 | $10,499 | 52.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 38 | 52 | $27,117 | $9,953 | 36.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 33 | 51 | $21,780 | $6,980 | 32.0% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 16 | 22 | $19,140 | $6,750 | 35.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 37 | 58 | $20,125 | $5,947 | 29.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 15 | 35 | $15,483 | $5,167 | 33.4% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 16 | 24 | $9,432 | $4,558 | 48.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 12 | 16 | $8,848 | $3,109 | 35.1% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 15 | 35 | $7,839 | $2,842 | 36.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 22 | 32 | $6,984 | $2,793 | 40.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 43 | $3,912 | $2,465 | 63.0% |
| 62368 | Electronic analysis and reprogramming of spinal canal drug infusion pump | Office | 2023 | 17 | 44 | $4,004 | $1,405 | 35.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 26 | 26 | $1,196 | $453.75 | 37.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 13 | $1,482 | $441.10 | 29.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 11 | 12 | $1,332 | $433.15 | 32.5% |
| 62367 | Electronic analysis of spinal canal drug infusion pump | Office | 2023 | 11 | 16 | $1,024 | $347.90 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 316 | 976 | $148,352 | $65,658 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 275 | 275 | $91,300 | $34,666 | 38.0% |
About Dr. Che Torry, DO
Dr. Che Torry, DO is a Sports Medicine healthcare provider based in Newport News, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1326402116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Che Torry, DO has received a total of $43,393 in payments from pharmaceutical and medical device companies, with $8,657 received in 2024. These payments were reported across 394 transactions from 18 companies. The most common payment nature is "Travel and Lodging" ($17,655).
As a Medicare-enrolled provider, Torry has provided services to 3,091 Medicare beneficiaries, totaling 5,910 services with total Medicare billing of $579,894. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Interventional Pain Medicine
- Location Newport News, VA
- Active Since 04/08/2016
- Last Updated 07/02/2020
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1326402116
Products in Payments
- SYNCHROMED (Device) $12,024
- INTELLIS ADAPTIVESTIM (Device) $4,868
- SYNCHROMEDII (Device) $4,817
- INTELLIS (Device) $4,605
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $2,676
- PROCLAIM (Device) $2,447
- OSTEOCOOL RF ABLATION SYSTEM (Device) $1,707
- IFUSE IMPLANT SYSTEM (Device) $927.30
- VANTA ADAPTIVESTIM (Device) $838.65
- XTAMPZA (Drug) $425.49
- WaveWriter Alpha Prime 16 (Device) $360.70
- Spectra WaveWriter (Device) $202.75
- ACCURIAN (Device) $192.53
- Belbuca (Drug) $177.36
- Senza (Device) $150.56
- ITREL (Device) $145.56
- Superion Indirect Decompression System (Device) $141.48
- Prialt (Drug) $136.09
- Vanta (Device) $114.74
- WAVEWRITER ALPHA (Device) $98.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.